586 / 1609
Fig. 4. Biochemical relapse-free results for unfavorable-risk (Stage T2b, iPSA >10 ng/mL, or bGS ≥7) patients by treatment modality. (a)
All unfavorable cases: RP, EBRT <72 Gy, EBRT ≥72 Gy, PI, or COMB. (b) Excludes EBRT <72. Abbreviations as in Fig. ...